Get started
Author

Eliseo Serone

Observed names: E Serone, E. Serone, SERONE E, SERONE E., SERONE, ELISEO
ORCID: 0000-0002-4582-9731
Observed ORCID: 0000-0002-4582-9731
OpenAlex ID: A5003052971
Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation
2015 · Giampiero Porcu, Eliseo Serone, et al. · PLoS ONE · 46
PDF
Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort
2018 · Marco Mirani, Giuseppe Favacchio, et al. · Pharmacological Research · 31
Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia
2016 · John O. Mascarenhas, Josef T. Prchal, et al. · Blood · 31
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus
2012 · Domenico Frezza, Barbara Tolusso, et al. · Annals of the Rheumatic Diseases · 29
Safety and Efficacy of Combined Ruxolitinib and Decitabine in Patients with Blast-Phase MPN and Post-MPN AML: Results of a Phase I Study (Myeloproliferative Disorders Research Consortium 109 trial)
2016 · Raajit K. Rampal, John O. Mascarenhas, et al. · Blood · 14
The change in Ig regulation from children to adults disconnects the correlation with the 3’RR hs1.2 polymorphism
2014 · Eliseo Serone, Cristina Daleno, et al. · BMC Immunology · 9
PDF
Association between Psoriasis and haplotypes of the IgH 3' Regulatory Region 1
2018 · Pietro D'Addabbo, Eliseo Serone, et al. · Gene · 7
The functional VNTR of IGH enhancer HS1.2 associates with human longevity and interacts with TNFA promoter diplotype in a population of Central Italy
2014 · Valerio Napolioni, Eliseo Serone, et al. · Gene · 6
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients
2012 · S. Canestri, M.C. Totaro, et al. · Reumatismo · 6
PDF
Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial
2016 · Ruben A. Mesa, Ronald Hoffman, et al. · Blood · 5
The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease.
2016 · R Cianci, S Lolli, et al. · PubMed · 5
Association between IgH enhancer hs1.2 and type 1 diabetes
2018 · Rossella Cianci, Pietro D’Addabbo, et al. · Acta Diabetologica · 4
New insight of human-IgH 3′regulatory regions in immunoglobulins switch
2023 · Rossella Cianci, Giorgio Mancino, et al. · Gene · 3
PDF
Concerted variation of the 3′ regulatory region of Ig heavy chain and Gm haplotypes across human continental populations
2020 · Domenico Frezza, Cristina Martinez‐Labarga, et al. · American Journal of Physical Anthropology · 3
HS1,2 Ig Enhancer Alleles Association to AIDS Progression in a Pediatric Cohort Infected with a Monophyletic HIV-Strain
2014 · Carla Montesano, Vincenzo Giambra, et al. · BioMed Research International · 3
PDF
Exploring the Potential of JAK1/2 Inhibitor Ruxolitinib with Reduced Intensity Hematopoietic Cell Transplantation (HCT) for Myelofibrosis: Stage I Results of a Prospective Trial Conducted through the Myeloproliferative Disorders - Research Consortium (MPD-RC)
2016 · Vikas Gupta, Heidi E. Kosiorek, et al. · Blood · 2
Balkan Endemic Nephropathy Risk Associates to the hs1.2 Ig Enhancer Polymorphism
2012 · D. Frezza, E. Serone, et al. · European Journal of Inflammation · 2
PORCU G, SERONE E, DE NARDIS V., NOCITA E., BOCCUNI L., POMA A AND A. RAGNINI-WILSON A multiparametric phenotypical screen combined with drug library repositioning identifies two Smoothened agonists as potent activators of oligodendrocyte-mediated myelination Gordon Conference Myelin , Lucca 15 maggio 2016 Renaissance Tuscany Il Ciocco in (Barga) Italy
2016 · Porcu, G, SERONE, ELISEO, et al. · Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila
THU0148 Asssociation of the 22 Genotype of Enhancer HS1,2A of the IG Heavy 3′ Regulatory Region with Non Response to Dmards and Response to Rituximab in Rheumatoid Arthritis Patients
2013 · B. Tolusso, E. Gremese, et al. · Annals of the Rheumatic Diseases
Study of the mechanism of glucocorticoid-induced myelin gene expression in mouse oligodendrocyte cell lines
2013 · SERONE E, PORCU G, et al. · Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila
AB0023 Gene-gene interaction and early rheumatoid arthritis: effects on the response to therapy
2012 · M.C. Totaro, B. Tolusso, et al. · Annals of the Rheumatic Diseases
Polymorphisms of the Ig heavy chain 3’ Regulatory Region associates with humoral Ig Homeostasis. (176.13)
2012 · Domenico Frezza, Eliseo Serone, et al. · The Journal of Immunology
AssociationbetweentheresponsetoB celldepletiontherapyandtheallele*2 oftheHS1,2Aenhancerinseropositive rheumatoidarthritispatients
2012 · S. Canestri, Eliseo Serone, et al.
Allelic frequencies of enhancer hs1.2 from Africa to Eurasia
2012 · Domenico Frezza, Cristina Martínez‐Labarga, et al.
3D conformational analysis of the Immunoglobulin 3’ Regulatory region
2012 · SERONE E., SETTE M., et al. · Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila
Works count: 28
Citation count: 206
H-index: 7
I10-index: 5
Year
Topic
Type